G01N 33/57525
Of the liver or pancreas
Official title: of the liver or pancreas
G01N33/57525 (Of the liver or pancreas) appears on 713 US grants and 1,599 published applications in this corpus.
Search patents in G01N- Granted patents
- 713
- Published applications
- 1,599
- Assignees
- 768
- Inventors
- 3,219
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 5 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 3 | 0 |
| 1996 | 6 | 0 |
| 1997 | 4 | 0 |
| 1998 | 3 | 0 |
| 1999 | 3 | 0 |
| 2000 | 6 | 0 |
| 2001 | 6 | 2 |
| 2002 | 1 | 18 |
| 2003 | 3 | 17 |
| 2004 | 5 | 13 |
| 2005 | 5 | 42 |
| 2006 | 6 | 41 |
| 2007 | 6 | 47 |
| 2008 | 12 | 35 |
| 2009 | 16 | 58 |
| 2010 | 17 | 67 |
| 2011 | 22 | 73 |
| 2012 | 25 | 83 |
| 2013 | 31 | 62 |
| 2014 | 44 | 101 |
| 2015 | 38 | 93 |
| 2016 | 54 | 117 |
| 2017 | 43 | 94 |
| 2018 | 45 | 93 |
| 2019 | 41 | 79 |
| 2020 | 45 | 76 |
| 2021 | 28 | 88 |
| 2022 | 40 | 69 |
| 2023 | 33 | 55 |
| 2024 | 37 | 75 |
| 2025 | 41 | 57 |
| 2026 | 22 | 44 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Molecular profiling of tumors6 Oct 2026US 12,754,193 B2Caris MPI, Inc.
- Cancer biomarker in pancreatic cancer or malignant intraductal papillary mucinous neoplasm15 Sep 2026US 12,736,536 B2National University Corporation Gunma University
- Antibody assay for the detection and treatment of liver cancer25 Aug 2026US 12,716,896 B2Freenome Holdings, Inc.
- Composition for cancer diagnosis18 Aug 2026US 12,710,425 B2Acurasysbio Co., Ltd.
- Molecular profiling of tumors21 Jul 2026US 12,687,554 B2Caris MPI, Inc.
- Method to induce exfoliation of cells and/or tissue fragments for enhanced cytopathologic cell collection8 Oct 2026US 2026/0306077 A1Adenocyte Ltd.
- Electrochemical biosensors, systems, and methods of use8 Oct 2026US 2026/0309671 A1
- Novel blood biomarker gulp1 for diagnosing liver cancer and use thereof1 Oct 2026US 2026/0297681 A1Ajou University Industry-Academic Cooperation Foundation
- Use of kit for diagnosing or assisting in diagnosis of spn1 Oct 2026US 2026/0298937 A1Junmo (Beijing) Biotherapeutics Co., Ltd.
- Methods for the assessment of risk and treatments for liver cancers and lethal liver disease complications24 Sep 2026US 2026/0287589 A1Board of Regents, The University of Texas System
Most cited
By later US patents
- Human FGF-21 nucleic acids138US 6,716,626 B1Chiron Corporation · 2004
- Pancreatic cancer targets and uses thereof104US 7,473,531 B1Colora Corporation · 2009
- Human FGF-21 polypeptides95US 7,259,248 B2Chiron Corporation · 2007
- Pancreatic cancer secreted targets and uses thereof95US 7,358,231 B1Applera Corporation · 2008
- AIMP2-DX2 gene and SiRNA targeting AIMP2-DX294US 8,003,780 B2Neomics Co., Ltd. · 2011